Results 121 to 130 of about 4,990 (166)

Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. [PDF]

open access: yesJ Infect Dis
Jost S   +11 more
europepmc   +1 more source

JC Polyomavirus Infection Potentiated by Biologics

Infectious Disease Clinics of North America, 2020
The risk of JC polyomavirus encephalopathy varies among biologic classes and among agents within the same class. Of currently used biologics, the highest risk is seen with natalizumab followed by rituximab. Multiple other agents have also been implicated.
Ashrit, Multani, Dora Y, Ho
openaire   +2 more sources

The biology of JC polyomavirus

Biological Chemistry, 2017
Abstract JC polyomavirus (JCPyV) is the causative agent of a fatal central nervous system demyelinating disease known as progressive multifocal leukoencephalopathy (PML). PML occurs in people with underlying immunodeficiency or in individuals being treated with potent immunomodulatory therapies.
Benedetta Assetta, Walter J. Atwood
openaire   +2 more sources

Evolution of human polyomavirus JC

Microbiology, 2000
More than 20 near full-length genome sequences have been reported for human polyomavirus JC (JCV). These have previously been classified into seven genotypes, and additional subtypes, which exhibit geographical associations. One of these genotypes, Type 4, has been suggested to be a recombinant of Types 1 and 3.
J N, Hatwell, P M, Sharp
openaire   +2 more sources

Infection with polyomavirus JC

BMJ, 2011
Is highly prevalent, and can be fatal in immunocompromised people The recent discovery of new neurological syndromes that result from neuronal infection with polyomavirus JC, also known as JC virus, and the presence of this virus in the grey matter are currently under debate.1 It has been suggested that JC virus is associated with cognitive decline ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy